| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/10/2008 | CN100417384C Herbeishatan hydrochlorothiazine dispersion tablet |
| 09/10/2008 | CN100417383C Effervescent tablet containing cefixime and its preparing method |
| 09/10/2008 | CN100417382C Minoxidil solution and preparing method of minoxidil liniment tablet |
| 09/10/2008 | CN100417381C Nicorandil freeze-drying powder preparation method |
| 09/10/2008 | CN100417380C Dialysate amino acid powder/liquid, and its compound dialysate power/liquid and preparing method |
| 09/10/2008 | CN100417378C Oridonin clathrate compound, and medicinal prepn. thereof |
| 09/10/2008 | CN100417376C Cataplasma of bulleyaconitine A |
| 09/10/2008 | CN100417375C Method for prodn. of dripping pills of andrographolide |
| 09/09/2008 | USRE40493 Porous paclitaxel matrices and methods of manufacture thereof |
| 09/09/2008 | US7424529 System using host bus adapter connection tables and server tables to generate connection topology of servers and controllers |
| 09/09/2008 | US7423179 Used to treat mood disorders (e.g., depression), anxiety disorders (e.g., obsessive compulsive disorder), behavioral disorders, eating disorders, substance abuse disorders and sexual disorders and for prevention of migraines |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423028 Injectable pharmaceutical compositions comprising sodium diclofenac and β-cyclodextrin |
| 09/09/2008 | US7423022 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 09/09/2008 | US7423010 Delivering into phagocytic cells; targeting specific organelles; inhibiting, attenuating, arresting, combating and overcoming microbial infection of phagocytic mammalian cells in vivo and in vitro |
| 09/09/2008 | US7423004 Provide improved solubility and dissolution, as well as enhanced bioavailability of particulate pharmaceuticals; without the need for using organic solvents and without the need to heat the compound to temperatures above its melting point |
| 09/09/2008 | US7422902 Nucleic acid encapsulated in cationic lipid, e.g., dimethyldioleoylammonium chloride, non-cationic lipid, e.g., palmitoyl oleoyl phosphatidylcholine, and polyethylene glycol-conjugated lipid that inhibits aggregations of particles; resistant in aqueous solution to degradation with a nuclease |
| 09/09/2008 | US7422758 Sustained release vitamin composition |
| 09/09/2008 | US7422757 Granulating heated mixture containing an active lipophilic substance and a surfactant; cooling to semi-solid state; mixing with fillers; sieving of the covered granules into a size below 1 mm,mixing with tabletting aids, and compressing into tablets |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | US7422574 Microseeding device for gene delivery by microneedle injection |
| 09/09/2008 | US7422110 Titration/compliance pack with increasing doses |
| 09/09/2008 | CA2474904C Once-a-day oxycodone formulations |
| 09/09/2008 | CA2451842C Chewable product including active ingredient |
| 09/09/2008 | CA2409069C Hydrogel composition for transdermal drug delivery |
| 09/09/2008 | CA2362769C Microcapsules for sustained release of drugs |
| 09/09/2008 | CA2346868C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 09/09/2008 | CA2346069C Tablet and tablet production method |
| 09/09/2008 | CA2336712C Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels |
| 09/09/2008 | CA2332389C Liposomal preparations for the application of antiseptic agents to the interior of the body |
| 09/09/2008 | CA2263445C Pharmaceutical aerosol composition |
| 09/09/2008 | CA2242631C Polymers with controlled physical state and bioerodibility |
| 09/09/2008 | CA2171369C The use of virulence factors of pathogens to improve liposomal delivery of antibiotics and/or vaccines |
| 09/09/2008 | CA2162299C Pharmaceutical composition for oral delivery of flavonoids |
| 09/09/2008 | CA2144449C Polymer composition |
| 09/04/2008 | WO2008106689A2 Breakthrough pain management |
| 09/04/2008 | WO2008106646A2 Methods and formulations for topical gene therapy |
| 09/04/2008 | WO2008106571A2 Sustained release parenteral formulations of buprenorphine |
| 09/04/2008 | WO2008106503A2 Discrete size and shape specific pharmaceutical organic nanoparticles |
| 09/04/2008 | WO2008106401A1 Very-pure superporous hydrogels having outstanding swelling propertles |
| 09/04/2008 | WO2008106228A2 Methods and compositions for normalizing meibomian gland secretions |
| 09/04/2008 | WO2008106220A1 Transdermal drug delivery systems for delivery with controlled heat |
| 09/04/2008 | WO2008106129A2 Polymeric micelles for combination drug delivery |
| 09/04/2008 | WO2008106094A1 Bio-absorbable oil suspension |
| 09/04/2008 | WO2008105791A2 Collagen scaffolds, medical implants with same and methods of use |
| 09/04/2008 | WO2008105773A2 System for targeted delivery of therapeutic agents |
| 09/04/2008 | WO2008105739A1 Drug implant carrier for drug delivery |
| 09/04/2008 | WO2008105663A1 Implant containing destructurized starch |
| 09/04/2008 | WO2008105662A1 Biodegradable material based on opened starch |
| 09/04/2008 | WO2008105507A1 Therapeutic agent for spinal cord injury |
| 09/04/2008 | WO2008105504A1 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same |
| 09/04/2008 | WO2008105475A1 Lipid composition having excellent shape retention property and product |
| 09/04/2008 | WO2008105445A1 Transdermal pharmaceutical composition |
| 09/04/2008 | WO2008105384A1 Citrulline-containing tablet |
| 09/04/2008 | WO2008105325A1 Citrulline-containing beverage |
| 09/04/2008 | WO2008105178A1 Agent for enhancing the resistance of liposome against biological component, and liposome modified with the agent |
| 09/04/2008 | WO2008105174A1 Liposome for induction of cell-mediated immunity |
| 09/04/2008 | WO2008105088A1 Agent for treating spinal cord injury |
| 09/04/2008 | WO2008105038A1 Adhesive patch for mycosis |
| 09/04/2008 | WO2008104996A2 Water dispersible pharmaceutical formulation and process for preparing the same |
| 09/04/2008 | WO2008104968A1 Spray administration of compositions including active agents such as peptides to the gastrointestinal tract |
| 09/04/2008 | WO2008104960A2 Personal care product comprising cyclodextrin as fragrance- complexing material |
| 09/04/2008 | WO2008104954A2 Personal care product comprising cyclodextrin as fragrance-complexing material |
| 09/04/2008 | WO2008104880A2 Stable solid dosage forms of an antidepressant |
| 09/04/2008 | WO2008104852A2 Pharmaceutical compositions comprising adsorbate of fenofibrate |
| 09/04/2008 | WO2008104846A2 Pharmaceutical compositions of fenofibrate |
| 09/04/2008 | WO2008104738A1 Improvements in and relating to medicinal compositions |
| 09/04/2008 | WO2008104635A1 Method for preparing silica compositions, silica compositions and uses thereof |
| 09/04/2008 | WO2008104633A1 Method for releasing a material in a controlled manner from amphiphilic compounds and use of the method |
| 09/04/2008 | WO2008104590A2 Novel dosage form |
| 09/04/2008 | WO2008104547A1 Medicated chewing gum |
| 09/04/2008 | WO2008104124A1 Screening method of combination pharmaceuticals, pharmaceuticals obtained by the method and uses thereof |
| 09/04/2008 | WO2008104076A1 Electrocolloidal silver and echinacea root antimicrobial formulation |
| 09/04/2008 | WO2008086804A3 Use of i) a polyglycol and n) an active drug substance for the preparation of a pharmaceutical composition for i) mitigating the risk of alcohol induced dose dumping and/or ii) reducing the risk of drug abuse |
| 09/04/2008 | WO2008064192A3 Modified release analgesic suspensions |
| 09/04/2008 | WO2008063301A3 Pharmaceutical compositions |
| 09/04/2008 | WO2008049903A3 Wide-area parasystemic treatment of skin related conditions |
| 09/04/2008 | WO2008043575A3 Improvements in or relating to amphoteric liposomes |
| 09/04/2008 | WO2008038140A3 Foamable vehicle comprising polypropylene glycol alkyl ether and pharmaceutical compositions thereof |
| 09/04/2008 | WO2008029264A3 Method of treating bone cancer |
| 09/04/2008 | WO2008019996A3 Formulations of flibanserin and method for manufacturing the same |
| 09/04/2008 | WO2008003003A3 Analyte monitoring and therapy management system and methods therefor |
| 09/04/2008 | WO2007132293A3 Once-daily administration of central nervous system drugs |
| 09/04/2008 | WO2007112339A3 Granular formulation |
| 09/04/2008 | WO2007100574A3 Biodegradable phosphoester polyamines |
| 09/04/2008 | US20080215037 Temperature responsive systems |
| 09/04/2008 | US20080214849 for transporting drugs or as gene transport vehicles, as solubilizers for drugs of low solubility in water, and themselves as active ingredients against diseases such as cancer or leishmaniosis; (Z)-6-octadecenyl-1-phospho-N,N,N-trimethylpropylammonium |
| 09/04/2008 | US20080214695 Biocompatible crosslinked polymers with visualization agents |
| 09/04/2008 | US20080214650 crystalline polymorphic dosage forms of anticholesterol agents; statins; small particle size distribution |
| 09/04/2008 | US20080214513 Method of treating middle ear infections |
| 09/04/2008 | US20080214510 Treating patient having meibomian gland disease, aqueous tear deficiency, delayed tear clearance or recurrent comeal epithelial erosion by topically administering an effective amount of tetracycline or derivative to eye |
| 09/04/2008 | US20080214463 Method for cell adhesion and wound healing |
| 09/04/2008 | US20080214438 Methods and Apparatus for Creating Particle Derivatives of HDL with Reduced Lipid Content |
| 09/04/2008 | US20080213475 Adhesive sheet and adhesive preparation, and production methods thereof |
| 09/04/2008 | US20080213467 Solution-based fabrication of photovoltaic cell |
| 09/04/2008 | US20080213393 Solid dosage forms; using polyoxyethylene glycol binder; antacids; antidepressants; blood pressure medications; calcium channel blockers; calcium supplements; chemotherapy medications; cold medicines; antihistamines; maintaining or promoting the elimination of feces in the bowel |
| 09/04/2008 | US20080213385 Formulations for 7- (T-Butoxy) Iminomethyl Camptothecin |
| 09/04/2008 | US20080213384 Spherical; react natural cyclodextrins with diphenyl carbonates as crosslinkers in the absence of a solvent by sonication; carrier of active ingredients, pharmaceuticals, food, cosmetic, phytopharmaceuticals; decontaminate polychlorobiphenyls, chlorinated and aromatic organic solvents |
| 09/04/2008 | US20080213383 Fine particles of poorly water-soluble drug having enteric material adsorbed on particle surface |
| 09/04/2008 | US20080213382 Thermotherapy susceptors and methods of using same |